Monday, April 27
7:00 am - 9:00 am
Location: 151A; BCEC
Advanced Practice Provider Fee: $150
Candidate and Medical Student Fee: $65
Moderator(s): Randy Lynn Jensen, MD, PhD, FAANS
Panelist(s): Lawrence S. Chin, MD, FAANS; Daniel A. Orringer, MD, FAANS ; Colin Watts, PhD (United Kingdom)
This seminar provides a state-of-the-art review of the different adjuvant treatment options available for patients with malignant brain tumors. Review current standards of care and then explore newer treatment options, including targeted therapies, intratumoral strategies, immunotherapeutic approaches and viral therapies.
Learning Objectives: After completing this educational activity, participants should be able to:
- Describe current standards of care for adjuvant therapy of malignant gliomas, as well as current scientific advances and newly developed adjuvant therapies.
- Discuss current problems with the design of effective therapies and recommend appropriate treatment options for patients with brain tumors.
- Design the best treatment programs based on current data.